In conclusion, our study identifies mutations in LRP1B, KMT2B, TSC2 and BRAF as significant prognostic markers in T1/2 CRC, along with critical clinical features such as lymphovascular invasion, poor tumour differentiation and aggressive histological types. Here, TSC2 is linked to neoplasm.